A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects

NCT04949490 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: BNT162b2s01
BIOLOGICAL: BNT162b2

Sponsor

BioNTech SE